Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma

NCT05151224 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Carcinoma

Interventions

DIAGNOSTIC_TEST: microRNA 21

Sponsor

Ain Shams University